Enzymatically modified LDL
lipoproteinAn enzymatically modified LDL variant that enhances macrophage lipid uptake and promotes plaque inflammation and lipid retention.
Pathway placement
Cascade stepLipid retention & oxidation
Confidencehigh
RationaleEnzymatically modified LDL drives macrophage uptake and is an atherogenic lipoprotein variant.
Also acts inVascular inflammation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Specialized reference method
Specimen
Serum or plasma (EDTA)
Collection tube
K2/K3-EDTA (lavender-top) · Serum separator (gold/red-top, SST)
Method / principle
Sandwich ELISA against the modified-apoB neoepitope
Reagent / substrate
Anti-modified-LDL monoclonal capture + anti-apoB detection
Platform
ELISA plate
Turnaround · availability
Research · Research/CE
Literature evidence(1)
- The Initial Human Atherosclerotic Lesion and Lipoprotein Modification-A Deep Connection.International journal of molecular sciences · 2021 · PMID 34768918 · doi